FLAD1
Basic information
Region (hg38): 1:154983338-154993111
Links
Phenotypes
GenCC
Source:
- myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Strong), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Moderate), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Definitive), mode of inheritance: AR
- myopathy with abnormal lipid metabolism (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Lipid storage myopathy due to FLAD1 deficiency | AR | Biochemical; Cardiovascular | Individuals have shown clinical improvement with dietary management (riboflavin); The condition has been described with cardiomyopathy, and awareness may allow prompt diagnosis and management (eg, with medical management and ICD) | Biochemical; Cardiovascular; Neurologic | 25058219; 27259049 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (261 variants)
- Inborn_genetic_diseases (70 variants)
- Myopathy_with_abnormal_lipid_metabolism (16 variants)
- FLAD1-related_disorder (10 variants)
- Multiple_acyl-CoA_dehydrogenase_deficiency (10 variants)
- not_specified (9 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLAD1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000025207.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 81 | 83 | ||||
| missense | 147 | 14 | 163 | |||
| nonsense | 8 | |||||
| start loss | 0 | |||||
| frameshift | 12 | 16 | ||||
| splice donor/acceptor (+/-2bp) | 4 | |||||
| Total | 19 | 9 | 150 | 95 | 1 |
Highest pathogenic variant AF is 0.000024163568
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FLAD1 | protein_coding | protein_coding | ENST00000292180 | 7 | 9774 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00936 | 0.990 | 125706 | 0 | 42 | 125748 | 0.000167 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.581 | 306 | 336 | 0.911 | 0.0000190 | 3728 |
| Missense in Polyphen | 92 | 103.66 | 0.88755 | 1144 | ||
| Synonymous | 1.72 | 111 | 137 | 0.812 | 0.00000702 | 1273 |
| Loss of Function | 3.07 | 8 | 24.4 | 0.328 | 0.00000131 | 271 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000416 | 0.000416 |
| Ashkenazi Jewish | 0.000202 | 0.000198 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000194 | 0.000193 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000163 | 0.000163 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the adenylation of flavin mononucleotide (FMN) to form flavin adenine dinucleotide (FAD) coenzyme. {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:27259049}.;
- Disease
- DISEASE: Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency (LSMFLAD) [MIM:255100]: An autosomal recessive, inborn error of metabolism characterized by variable mitochondrial dysfunction. Clinical features range from severe cardiac and respiratory insufficiency with onset in infancy and resulting in early death, to mild muscle weakness with onset in adulthood. Some patients show significant improvement with riboflavin treatment. Analysis of skeletal muscle show multiple mitochondrial respiratory chain deficiency and a lipid storage myopathy in most patients. {ECO:0000269|PubMed:27259049}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Riboflavin metabolism - Homo sapiens (human);Riboflavin Metabolism;Selenium Micronutrient Network;Folate Metabolism;Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;flavin biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.0672
- rvis_EVS
- -1.04
- rvis_percentile_EVS
- 7.71
Haploinsufficiency Scores
- pHI
- 0.114
- hipred
- N
- hipred_score
- 0.371
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Flad1
- Phenotype
Gene ontology
- Biological process
- FAD biosynthetic process;riboflavin metabolic process
- Cellular component
- mitochondrial matrix;cytosol;plasma membrane
- Molecular function
- FMN adenylyltransferase activity;protein binding;ATP binding